Cancer Research and Biotechnology

Biotechnology Research • Baar, Zug, Switzerland • 1-10 Employees

Company overview

Headquarters	Zugerstrasse 72, Baar, Zug CH-6340, CH
Phone number	+41415100134
Website	crab.ch
NAICS	541714
Keywords	Research, Development, Dementia, Cancer, Oncology, Inflammation, Epigenetics, Longevity, Cancer Prevention, Metabolism, Orphan Diseases, Parkinson'S, Pancreatic Cancer, Breast Cancer, Apoptosis, Healthy Aging, Mitochondria, Colorectal Cancer, Mutations, Carcinogens, Intracellular, Altzheimer'S, Degerative Diseases, Genetic Errors, Tnbc, Reverse Carcinogenesis, Triple-Negative Breast Cancer
Founded	2019
Employees	1-10
Socials

Key Contact at Cancer Research and Biotechnology

Kari Sarvanto

CEO & Founder

About Cancer Research and Biotechnology

Cancer Research and Biotechnology AG (CRB) is a late preclinical biopharma company, it has developed treatments for cancer and other degenerative diseases based on its discovery and innovation in Reverse Carcinogenesis. The first drug candidate has patents pending, and early proof of concept is documented. The safety for human use is already well established already during the preclinical stage. We found that cancer can be curable as it is a metabolic disease by its origin. CRB is developing innovations to reverse the cellular processes that lead to mitochondrial dysfunctions - the root cause of genetic errors and degeneration leading to tumors. Healthy aging is a reality. The first target disease is triple-negative breast cancer (TNBC), a hard-to-treat cancer attacking younger women and mothers. We now have shown dramatic efficacy in several hard-to-treat cancers, such as 50% tumor volume reduction where no treatment exists today.

Cancer Research and Biotechnology revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Cancer Research and Biotechnology has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Cancer Research and Biotechnology has never raised funding before.

Cancer Research and Biotechnology Tech Stack

Discover the technologies and tools that power Cancer Research and Biotechnology's digital infrastructure, from frameworks to analytics platforms.

Elementor

Page builders

Astra

WordPress themes

Gravity Forms

Form builders

jQuery

JavaScript libraries

Elementor Header & Footer Builder

WordPress plugins

PHP

Programming languages

Open Graph

Miscellaneous

Font Awesome

Font scripts

Essential Addons for Elementor

WordPress plugins

WordPress

Blogs

ZURB Foundation

UI frameworks

jQuery Migrate

JavaScript libraries

Frequently asked questions

Cancer Research and Biotechnology is located in Baar, Zug, CH.

You can reach Cancer Research and Biotechnology at +41415100134.

Cancer Research and Biotechnology was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Cancer Research and Biotechnology has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Cancer Research and Biotechnology

Kari Sarvanto

CEO & Founder

4.8

40,000 users